Volume 1, Number 3Review ArticlesLaser Prostatectomy: Checkup on the PromisesClinical ChallengeSteven A KaplanAlexis E TeJames ChoiEdward F IkeguchiProstatectomyBenign prostatic hyperplasia (BPH)Laser
Volume 6, Supplement 9SupplementAUA Guidelines and Their Impact on the Management of BPH: An UpdateSteven A KaplanBenign prostatic hyperplasiaMedical treatmentGuidelinesAmerican Urological AssociationSymptom score
Volume 7, Number 4Literature ReviewsBenign Prostatic HyperplasiaReviewing the LiteratureSteven A KaplanSusan R Rusnack
Volume 7, Supplement 7Review ArticlesFactors in Predicting Failure With Medical Therapy for BPHSteven A KaplanBenign prostatic hyperplasiaMedical therapyBlockers5-reductase inhibitorsPredictors of treatment failureClinical trial results
Volume 7, Supplement 8Review ArticlesThe Evolving Role of a-Blockers in Benign Prostatic Hyperplasia and BeyondSteven A Kaplan
Volume 7, Supplement 8Review Articlesa-Blocker Therapy: Current UpdateSteven A KaplanBenign prostatic hyperplasiaLower urinary tract symptomsBlockers
Volume 8, Supplement 4Review ArticlesUpdate on the American Urological Association Guidelines for the Treatment of Benign Prostatic HyperplasiaAdvances in Alpha-Blocker Therapy in the Management of Urological DisordersSteven A KaplanThe updated 2003 American Urological Association (AUA) Guidelines for the treatment of benign prostatic hyperplasia (BPH) are the culmination of an exhaustive effort predicated on scientifically accepted methods of reviewing the medical literature. In this second publication of the guidelines, a multidisciplinary panel reviewed a new meta-analysis of outcome data from the BPH literature from before and after 1994. The major differences between the 2 guidelines are the changes in our understanding of the biology of the prostate and the introduction of new therapies. The vast majority of randomized controlled trials, particularly with respect to minimally invasive therapies and progression of BPH, were performed after the release of the 1994 guidelines. Also, the most recent AUA panel carefully reviewed unpublished data to make the guidelines as timely as possible. Studies that were subsequently published included those on the value of combination medical therapy for BPH. The panel agreed on updated recommendations for the treatment of moderate-to-severe lower urinary tract symptoms associated with BPH, and diagnostic algorithms were revised. The durability and utility of the present guidelines should exceed that of its predecessor. [Rev Urol. 2006;8(suppl 4):S10-S17]Benign prostatic hyperplasiaLower urinary tract symptomsCombination therapy5-reductase inhibitorsAUA GuidelinesAUA Symptom Scores
Volume 8, Supplement 3Review ArticlesExpanding the Role of Photoselective Vaporization of the ProstatePhotoselective Vaporization of the ProstateSteven A KaplanThe use of the potassium-titanyl-phosphate (KTP) laser for the ablative treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) has gained wide acceptance in the urologic community. The efficacy and safety of photoselective vaporization of the prostate using 60-W or 80-W KTP have been demonstrated in multiple trials, with significant impact on special high-risk surgical populations (ie, patients with large prostates and anticoagulated patients with multiple comorbidities) with symptomatic BPH. The high-power KTP laser technique has also shown encouraging results in the management of urethral strictures. With catheter removal, improvement in voiding may not immediately occur; however, with the efficient vaporization and limited coagulation necrosis that are routinely noted with high-power KTP applications, improvement may occur in as early as a few days to 1 week. Because of the superior surgical hemostasis associated with laser prostatectomy, no restrictions on physical activity are required after the procedure, even in the immediate postoperative period. [Rev Urol. 2006;8(suppl 3):S3-S8]BPHUrethral stricturesProstatectomyKTP laserVaporization
Volume 8, Supplement 3Review ArticlesPhotoselective Vaporization of the Prostate: An Effective Procedure for the Treatment of Benign Prostatic HyperplasiaIntroductionSteven A Kaplan